Bandingkan Harga & Kinerja Nusa Palapa Gemilang Tbk. (NPGF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Nusa Palapa Gemilang Tbk. dan Organon Pharma Indonesia Tbk.: Nusa Palapa Gemilang Tbk. diperdagangkan di Rp57 (kapitalisasi pasar 187,93 M, volume 24 jam 16,64 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Nusa Palapa Gemilang Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| NPGF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 187,93 M | 104,4 M |
Volume | 16,64 jt | — |
Lot | 166,38 rb | — |
Perputaran | 953,63 jt | — |
Harga Rata-rata | 57,32 | — |
Nilai Transaksi | 953,63 jt | — |
Harga Ekuilibrium Indikatif | 57 | — |
Volume Ekuilibrium Indikatif | 450 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Nusa Palapa Gemilang Tbk.
PT Nusa Palapa Gemilang Tbk (the Company) was established based on Notarial Deed No. 111 of Untung Darmosoewirjo S.H., dated November 29, 2001, a Notary in Surabaya.
Selengkapnya di halaman NPGF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
